Abstract:Ai-Yuan Xiu, 1 Qian Ding, 2 Zhen Li, 2 Chun-Qing Zhang 1, 2 1 Department of Gastroenterology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China; 2 Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China Correspondence: Chun-Qing Zhang Department of Gastroenterology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, 324 Jingwu Weiqi Road, Jinan, 250021, People's Republic of China Tel +86 5 316 877 3293 Fax +86 5 318 790 6348 Email Purpose: To investigate the effect of doxazosin on autophagy and the activation of hepatic stellate cells (HSCs) in vivo and in vitro and determine the underlying mechanism. Methods: In vivo, a mouse liver fibrosis model was induced by the intraperitoneal injection of carbon tetrachloride (CCl 4 ). Doxazosin was administered at doses of 2.5, 5 and 10 mg/(kg&astday) by gavage. After 20 weeks, blood and liver tissues were collected for serological and histological analysis, respectively. Blood analysis, hematoxylin and eosin (HE) staining, Masson's trichrome staining, immunohistochemistry and immunofluorescence staining were used to measure the extent of liver fibrosis in model and control mice. In vitro, the human HSC cell line LX-2 was cultured and treated with different doses of doxazosin for the indicated times. The effects of doxazosin on LX-2 cell proliferation and migration were examined by Cell Counting Kit-8 (CCK-8) and Transwell assays, respectively. The number of autophagosomes in LX-2 cells was observed by transmission electron microscopy (TEM). Infection with green fluorescent protein (GFP)-LC3B adenovirus, GFP-red fluorescent protein (RFP)-LC3B adenovirus and mCherry-EGFP-LC3 adeno-associated virus was performed to examine changes in autophagic flux in vitro and in vivo. Cell apoptosis was measured by flow cytometry in vitro and by TUNEL assays both in vitro and in vivo. Immunoblotting was performed to evaluate the expression levels of proteins related to fibrosis, autophagy, apoptosis, and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR). Results: Doxazosin inhibited HSC proliferation and migration. HSC activation was attenuated by doxazosin in a concentration-dependent manner in vivo and in vitro. Doxazosin also blocked autophagic flux and induced apoptosis in HSCs. In addition, the PI3K/Akt/mTOR pathway was activated by doxazosin and regulated fibrosis, autophagy and apoptosis in HSCs. Conclusion: The study confirmed that doxazosin could inhibit autophagy by activating the PI3K/Akt/mTOR signaling pathway and attenuate liver fibrosis. Keywords: doxazosin, liver fibrosis, autophagy, apoptosis, mTOR Liver fibrosis is a complicated pathophysiological process that serves as an intermediate stage for various chronic liver diseases, including liver cirrhosis. 1 Portal hypertension (PHT) and hepatic failure usually occur in the late stage of liver cirrhosis. 2 Although strategies for the diagnosis and treatment of liver cirrhosis have improved, this disease still causes more than one million deaths each year worldwide. 3 Thus far, apart from ameliorating the underlying cause or performing liver transplantation, no effective clinical therapies are available to inhibit the pathological progression of liver fibrosis, 4 and safe and effective drugs are urgently needed. The activation of hepatic stellate cells (HSCs) is crucial for liver fibrogenesis because they transdifferentiate into myofibroblasts, which are the primary cells responsible for synthesizing the extracellular matrix (ECM) in the liver. 5 Activated HSCs can produce alpha smooth muscle actin (α-SMA) and type I collagen (COL1, formed by two molecules of COL1A1 and one molecule of COL1A2), 6 , 7 ultimately leading to an imbalance in ECM production and degradation. Autophagy is a crucial intracellular pathway, through which damaged organelles and impaired proteins are degraded to supply eukaryotic cells with energy to maintain homeostasis. 8 Previous studies have shown that the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway plays an important role in regulating cellular autophagy, including that in HSCs. 9–11 Autophagy can provide energy for HSC activat -Abstract Truncated-

Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway

Liver Fibrosis Therapy Based on Biomimetic Nanoparticles Which Deplete Activated Hepatic Stellate Cells.

Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer

Extent of extracellular signal-regulated kinases phosphorylation determines the sensitivity of hepatic stellate cells to staurosporine-induced apoptosis.

Autophagy affects hepatic fibrosis progression by regulating macrophage polarization and exosome secretion

SNS-032 attenuates liver fibrosis by anti-active hepatic stellate cells via inhibition of cyclin dependent kinase 9

Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?

Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis

MP06-13 AUTOPHAGY PROMOTES PROSTATIC FIBROBLAST ACTIVATION IN PROGRESSION OF BPH BY MODULATION OF LIPID METABOLISM

Anti-PCSK9 Treatment Attenuates Liver Fibrosis via Inhibiting Hypoxia-Induced Autophagy in Hepatocytes

Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis

Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation

IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway

Inhibition of inhibitor of κB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis

Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis

Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies

SIRT7 affects autophagy and activation of hepatic stellate cells by regulating the acetylation level of high mobility group protein 1

Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?

Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis